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Background/aim: Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a rare clinicoradiological syndrome
that typically presents with central nervous system symptoms such as loss of consciousness, seizure, headache, and ophthalmoparesis.
Materials and methods: Here, we highlight the characteristics of this syndrome together with the clinical and MRI findings of 6
pediatric patients with MERS.
Results: Between January 2017 and October 2020, 6 patients with MERS (3 boys and 3 girls) presented to our center. The mean age was
122 ± 54.6 (min-max: 44-180) months. None of the patients had a chronic disease. In our study, infectious agents were detected in 4
patients (66.6%), while noninfectious causes (one seizure and the other hyponatremia) were detected in two patients. All of our cases
were discharged without any sequelae after an average of 12.1 ± 7 (min–max: 4–20) days of hospitalization. In 1 patient (case 6), control
MRI could not be performed, and the radiological recovery of our other patients was shown to be between 14 days and 2 months.
Conclusion: MERS is an acute encephalopathy with good prognosis and should be considered by neurologists in differential diagnosis
due to its variable clinical presentation and specific MRI findings.
Key words: MERS, childhood, treatment, prognosis

1. Introduction
Mild encephalitis/encephalopathy with a reversible splenial
lesion (MERS) is a rare clinicoradiological syndrome that
typically presents with central nervous system symptoms
such as loss of consciousness, seizure, headache, and
ophthalmoparesis. Although its pathogenesis is not fully
understood, causes such as infectious agents (e.g., rotavirus,
adenovirus, influenza A and B, dengue virus, mumps,
Mycoplasma pneumoniae, Streptococcus pneumoniae),
hyponatremia, and the use or discontinuation of
antiepileptic drugs have been implicated in the literature.
The prognosis is generally good, as clinical and imaging
findings resolve completely within a few months [1–6].

The condition is subdivided into two types based on the
extent of involvement. In MERS type 1, which is the more
common type, lesions are limited to the corpus callosum
splenium, while, in MERS type 2, the lesions involve the
whole corpus callosum or spread symmetrically to the
white matter. The absence of gadolinium enhancement in
the white matter lesions, the presence of reversible diffusion
restriction in MRI, and the hyperintense appearance in
fluid-attenuated inversion recovery (FLAIR) and T2weighted sequences suggest a process characterized by
separation of the myelin layers due to edema and local
infiltration of inflammatory cells [7]. Although most cases
have been reported from the Asian continent, especially
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from Japan, cases have also been reported from various
European nations, including our country [3,8]. Here, we
highlight the characteristics of this syndrome together
with the clinical and MRI findings of 6 pediatric patients
with MERS.
2.Patients and methods
Six pediatric patients diagnosed with MERS according
to the Takanashi [7] diagnostic criteria between January
2017 and September 2020 in the SBU Dr. Sami Ulus
Gynecology, Obstetrics and Pediatrics Training and
Research Hospital were included in the study. Patient
data such as demographic characteristics, prodromal
and neurological symptoms, neurological examination
findings, MRI, and electroencephalogram (EEG) findings,
laboratory results, treatment, and outcomes were
reviewed. All MRI examinations included T2-weighted,
FLAIR, T1-weighted, contrast-enhanced T1-weighted
imaging, diffusion-weighted imaging (DWI), and apparent
diffusion coefficient (ADC) maps. All MRI examinations
were evaluated by an experienced pediatric radiologist.
MRI and EEG were performed within 48 h of the onset of
neurological symptoms (mean 24.8 ± 22.3 h for MRI and
22.6 ± 20.8 h for EEG).
3.Results
Between January 2017 and October 2020, 6 patients with
MERS (3 boys and 3 girls) presented to our center. The
mean age was 122 ± 54.6 (min-max: 44–180) months
(Table). None of the patients had any chronic diseases.
3.1. Case 1
A 4-year-old girl with no previous complaints was admitted
to the emergency department with fever for 2 days and
transient vision loss that recurred several times during
the day. General physical examination and vital signs were
normal; hemogram and biochemical parameters showed
no abnormalities.
Detailed eye examination and EEG findings were
normal. On lumbar puncture, cerebrospinal fluid (CSF)
parameters were normal, and no microorganisms were
detected in direct examination. Brain MRI revealed a
hyperintense, diffusion-restricting oval lesion in the
splenium of the corpus callosum in T2-weighted sequences
(Figures 1a,1b). Infectious and metabolic evaluations
revealed no factors that could explain this clinical and
neuroradiological presentation. Cranial MRI obtained at
1-month follow-up showed that the lesion had resolved
(Figures 1c,1d).
3.2. Case 2
A 12-year-old previously healthy girl presented with
symptoms of upper respiratory tract infection for 3-4
days and sudden-onset strabismus with double vision.
Vital signs were normal and physical examination was
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unremarkable except for the restricted movement of the left
eye. Fundus examination was normal, and laboratory tests
indicated that hemogram and biochemistry parameters
were within reference ranges.
Brain MRI showed a diffusion-restricting millimetric
lesion in the corpus callosum splenium that was
hypointense in T1-weighted and hyperintense in T2weighted sequences (Figures1e–1g). In etiological
investigations, EEG was normal, CSF opening pressure
on lumbar puncture was 58 cmH2O, CSF parameters were
normal, and no microorganisms were detected on direct
examination. Among infectious parameters, Epstein–Barr
virus (EBV) capsid antigen antibodies (immunoglobulin
[Ig] M and G) were positive, EBV nuclear antigen (EBNA)
IgG antibodies were negative, and polymerase chain
reaction (PCR) assay revealed an EBV load of 3.2×103
copies/L. CSF PCR testing was negative for EBV and
other pathogens. Based on these clinical, serological,
and radiological results, she was diagnosed with MERS
due to primary EBV infection. She was followed without
treatment and brain MRI examination at the first month
showed that the lesions had resolved (Figures 1h,1ı).
3.3 Case 3
A 5-year-old girl who had no known illnesses was referred
to us due to prodromal symptoms such as diarrhea and
fever for 2 days, transient generalized tonic clonic seizures
that occurred 3 times in the same day, and sleepiness. At
admission, her Glasgow Coma Scale (GCS) score was
13 (eye opening response: 4, verbal response: 4, motor
response: 5) and other vital signs were normal except
for a temperature of 38.2°C. She was slightly dehydrated
and drowsy but there was no focal neurological deficit.
Laboratory tests indicated normal hemogram and
biochemical parameters. The first EEG was performed 1
day after admission and demonstrated diffuse slowing but
no epileptic activity. On lumbar puncture, CSF protein
and glucose levels were normal, and no microorganisms
were detected in direct examination. Brain MRI revealed
increased T2 signal intensity in the dentate nucleus
and middle cerebellar peduncle in the right cerebellar
hemisphere, intense contrast enhancement in the
cerebellar foliage, diffusion restriction at the level of
the dentate nucleus and middle cerebellar peduncle in
DWI arrays, and hyperintense, diffusion-restricting oval
lesions in the corpus callosum splenium in T2-weighted
and FLAIR sequences (Figures 1j–1m). Rotavirus RNA
was detected in stool by PCR but could not be evaluated
in CSF. Encephalitis was suspected due to the presence
of fever accompanied by drowsiness, and treatment with
ceftriaxone and acyclovir was initiated. During follow-up,
the patient’s drowsiness regressed, but she showed signs of
ataxia and aphasia. Intravenous immunoglobulin (IVIg)
was administered, but there was no clinical response.
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Table. The clinical findings in the pediatric patients presenting with reversible splenial lesion syndrome.
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Figure 1. (a-n) legend: a: Diffusion-weighted image of the patient shows restricted diffusion in the splenium of the corpus
callosum (arrow). b: FLAIR image demonstrates high signal intensity in the splenium of the corpus callosum(arrow). c,d:On follow-up
MRI, the lesion in the splenium of corpus callosum was totally resolved. e: Diffusion-weighted image of the patient reveals restricted
diffusion in the splenium of the corpus callosum (arrow). f: Axial plane FLAIR and g: coronal plane T2 weighted images demonstrate
high signal lesion in the splenium of the corpus callosum compatible with edema (arrow). h,ı:On follow-up MRI, the lesion in the
splenium of corpus callosum was totally gone. j: FLAIR image of brain MRI shows high signal intensity in the splenium of the corpus
callosum (arrow). k,l: Diffusion-weighted image shows restricted diffusion in the splenium of the corpus callosum and right side of the
middle cerebellar peduncle. m: Post contrast T1 weighted image shows the leptomeningeal enhancement of the cerebellar folia more
prominent on the right side than the left compatible with cerebellitis (arrows). n: On the follow-up MRI, the DWI image reveals the
restricted diffusion in the splenium of corpus callosum was totally gone.

CSF viral PCR test and blood and CSF cultures were
negative, and treatment with pulse methylprednisolone
was initiated. Her general condition gradually improved,
and she was discharged with no sequelae on day 16 of
hospitalization. Brain MRI examination at 2 months
showed that the lesions had resolved (Figure 1n).
3.4. Case 4
A 13-year-old boy was admitted to our emergency
department with fever for 5 days, hypersomnia for 1
day, and an ataxic gait. It was learned that his family had
coronavirus disease 2019 (COVID-19) 15 days earlier, and
the patient had been in quarantine with contact isolation.
A COVID-19 test was negative at that time. His body
temperature was 39 °C, respiration rate was 30 breaths/
min, oxygen saturation was 96% in room air, and blood
pressure was 122/69 mmHg. He had transient agitation,
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excessive sleepiness, loss of orientation to place and time,
and his GCS score was 13 (eye-opening response: 4, verbal
response: 4, motor response: 5). Laboratory test results
were as follows: hemoglobin 12.9 g/dL, leukocyte count
14100/μL, platelet count 73000/μL, serum sodium 135
mmol/L, alanine aminotransferase 345 U/L, aspartate
aminotransferase 295 U/L, and C-reactive protein 342
mg/L. Asymmetric septal hypertrophy and myocarditis
were detected on echocardiography.
Real-time polymerase chain reaction (RT-PCR) of
a nasopharyngeal swab sample remained negative for
severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) but anti-SARS-CoV-2 IgM and IgG were detected
in the patient’s serum. Brain MRI showed a hyperintense,
diffusion-restricting lesion in the corpus callosum
splenium in T2-weighted and FLAIR sequences (Figure

YAVUZ et al. / Turk J Med Sci

Figure 2. (a–l) legend: a: Diffusion-weighted image of the patient shows restricted diffusion in the splenium of the corpus
callosum (arrow). b: Note the low ADC value as a dark signal (arrow) in the ADC map. c: T2 weighted image demonstrates high signal
lesion in the splenium of the corpus callosum compatible with edema (arrow). d,e: On follow-up MRI, the lesion in the splenium
of corpus callosum was totally gone. f: FLAIR image of Brain MRI shows high signal lesion in the splenium of the corpus callosum
compatible with edema (arrow). g: Diffusion-weighted image of the patient shows restricted diffusion in the splenium of the corpus
callosum compatible with cytotoxic edema (arrow). h,ı: On the follow-up MRI, the FLAIR and DWI images reveal the enlargement of
edema in the splenium of corpus callosum (arrows). j: FLAIR image of the patient demonstrates high signal lesion in the splenium of
the corpus callosum(arrow). k: Diffusion-weighted image shows restricted diffusion in the splenium of the corpus callosum (arrow). l:
Note the low ADC values as a dark signal (arrow) in the ADC map regarding cytotoxic edema.

2 a,b,c), while EEG demonstrated diffuse slowing and no
epileptic activity. Based on these findings, he was admitted
to the pediatric intensive care unit (PICU) with a diagnosis
of multisystem inflammatory syndrome in children
(MIS-C). Treatment with IVIg and oral prednisone
was initiated. His fever and other symptoms (transient
agitation, excessive sleepiness, loss of orientation to
place and time) started to improve on day 2, and he was
discharged with no sequelae on day 14 of hospitalization.
Brain MRI examinations performed 2 weeks later showed
that the lesion had resolved (Figure 2 d,e).

3.5. Case 5
A 16-year-old boy with headache and fever for 4 days had
been treated at another medical center for a presumed
upper respiratory tract infection and was admitted to our
emergency department when his symptoms worsened
during follow-up. His temperature at admission to our
center was 39.2 °C and other vital signs were normal.
He exhibited neck stiffness on physical examination
and his GCS score was 15. There were no abnormalities
in hemogram and biochemical analyses. EEG showed
diffuse slowing and no epileptic activity. On lumbar
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puncture, CSF protein and glucose levels were normal,
and the white blood cell count was 40/mm3 on direct
CSF examination. Coxiella burnetti IgG was detected at
titers of 1/128 for phase I and 1/1024 for phase II, and
the patient was diagnosed as having Q fever-associated
meningoencephalitis. Brain MRI revealed a hyperintense,
diffusion-restricting lesion in the splenium of the corpus
callosum in T2-weighted and FLAIR sequences (Figure 2
f,g,h). The patient was treated with doxycycline, and his
clinical condition gradually improved until discharge on
day 20 of hospitalization. He had no sequelae, and no
lesion was observed on brain MRI examination 2 weeks
later (Figure 2ı).
3.6. Case 6
A 13-year-old boy presented to the emergency department
with complaints of abdominal pain and vomiting for 4
days. His vital signs were normal, but right lower quadrant
tenderness was noted on physical examination, and
abdominal ultrasound findings were compatible with
acute appendicitis. During preparation for surgery, he
exhibited nonsensical speech, excessive sleepiness, and
occasional agitation. Brain MRI showed a hyperintense,
diffusion-restricting lesion in the corpus callosum
splenium in T2-weighted and FLAIR sequences (Figure
2j–2l). There was diffuse slowing on EEG, and no epileptic
activity was detected. In laboratory tests, serum sodium
was 122 mmol/L, but other results were within the
normal range. With intravenous fluid therapy, his clinical
condition improved within 24 h, and an appendectomy
was performed. He was discharged with no sequelae on
day 16 of hospitalization. Control cranial MRI was not
performed because the patient had no complaints during
3 months of follow-up.
4. Discussion
MERS is a generally benign condition characterized by
mild central nervous system symptoms and a temporary
lesion in the splenium of the corpus callosum on cranial
MRI. It can occur after discontinuation of antiepileptic
drugs, abrupt cessation of steroid therapy, hypoglycemia,
and infections (especially viral upper respiratory tract
infections such as influenza and EBV). Patients typically
present with symptoms such as headache, confusion,
ataxia, seizure, delirium, and coma [9–10]. Although
factors such as cytotoxic edema, focal inflammatory
changes, electrolyte changes in the cell membrane, and
focal demyelination due to antiepileptic drugs have been
implicated, the reason for the specific involvement of
this region and its pathophysiological mechanisms have
not been clarified [11,12]. In this study, we describe
the clinical features and outcomes of 6 patients with

MERS who presented to the neurology department of a
tertiary health center. Prodromal symptoms in children
are not specific, and although fever is the most common
symptom, gastrointestinal and respiratory symptoms
have also been reported [8,13]. In our study, 4 (66.6%)
of our patients had prodromal symptoms in the form of
fever (66.6%), 1 (16.6%) as diarrhea, and 1 (16.6%) as
abdominal pain. In different case series, the most common
neurological symptoms have been reported as a change in
consciousness, behavioral change, ataxia, motor weakness,
and seizures. In two separate studies from Japan, it was
reported that 30% [13] and 50% (8) of pediatric cases
had seizures. In addition, in another study conducted
in Australia [14], it was found that 14.3% of children
with MERS presented with seizures. Consistent with the
literature, the neurological symptoms of our patients at
admission included change in consciousness, headache,
seizure, ataxia, and ophthalmoparesis.
Various infectious agents have been reported to
be associated with MERS in children. In our study,
infectious agents were detected in 4 patients (66.6%),
while noninfectious causes were detected in two patients
(seizure and hyponatremia).
One of our patients (case 3) developed febrile seizure,
ataxia, and aphasia after rotavirus enteritis. Chen et al. [15]
reported that 3 of 5 rotavirus-associated MERS patients
had febrile seizures in their study. Rotavirus-related MERS
or acute cerebellitis cases have been reported previously.
Also, Takanashi J. et al. [16] reported that 6 of 11 rotavirusassociated cerebellitis patients had a splenial lesion in MRI.
Similarly, in our study, we showed a spleen lesion on MRI
in our patient with rotavirus-associated acute cerebellitis.
EBV-related MERS has been reported in older adult
patients in the literature, but reports in children are
less common [17,18]. In our study, we detected MERS
associated with EBV infection in one of our patients (case
2). The patient presented with limited outward gaze and a
CSF opening pressure of 58 cmH2O. This suggested that
the ophthalmoparesis may have been due to increased
intracranial pressure.
Although COVID-19 is a severe lower respiratory
tract infection caused by SARS-CoV-21, an immunemediated syndrome called MIS-C has been identified in
pediatric patients and can cause different neurological
symptoms and splenial lesions on cranial imaging [19,20].
In our study, we detected MERS associated with SARSCoV-2 infection in one of our patients (case 4). It should
be kept in mind that children with COVID-19 infection
may develop MERS. Another of our patients (case 5) had
MERS associated with C. burnetti. As far as we know,
MERS associated with C. burnetti has not been reported

World Health Organization. (2020). Coronavirus disease 2019 (COVID-19): situation report, 73. World Health Organization. Available at: https://apps.
who.int/iris/handle/10665/331686
1
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previously in the literature. Our case is remarkable in this
respect.
Hyponatremia is another possible etiological factor in
MERS. It has been suggested that hypotonic hyponatremia
causes intramyelinic edema that results in transient
reduced diffusion on MRI [21]. Hyponatremia rates
reported in pediatric MERS vary greatly. Takanashi et al.
[21] detected hyponatremia in 25 (84%) of 30 pediatric
cases, while Zhang et al. [22] detected hyponatremia in
6 (24%) of 25 pediatric cases. We detected hyponatremia
in one of our patients (case 6), who presented with acute
appendicitis.
The most common EEG abnormality previously
described in MERS cases is diffuse slow waves [3,7]. In our
study, EEG was performed at a mean of 1.7 ± 0.5 (minmax: 1-2) days after admission and diffuse slowing was
detected in 4 patients (66.6%), while the results of the
other 2 patients (33.3%) were evaluated as normal. Our
study was found to be compatible with the literature in
this respect
Although there are no treatment guidelines for MERS,
specific immunomodulatory therapy is not recommended
because it has a generally good prognosis [3]. In our study,
3 patients (50%) improved clinically with treatment for
the primary cause. Of the other 3 patients, one patient was
treated with pulse methylprednisolone, IVIg, acyclovir,
and antibiotic therapy due to the presence of acute
cerebellitis with MERS; one patient was treated with
prednisolone, IVIg, acyclovir, and antibiotic therapy due to
the development of MIS-C secondary to SARS-CoV-2, and
one patient was treated with IVIg, acyclovir, and antibiotic
therapy due to encephalitis secondary to C. burnetti. All
patients were discharged without sequelae after a mean of
12.1 ± 7 (min–max: 4–20) days of hospitalization. Control
MRI was not performed in one patient (case 6), whereas
the other patients demonstrated radiological recovery
starting from the 14th day up to 2 months. However, the
exact timing of complete normalization in MRI findings

could not be determined because more frequent followup imaging is not available. In the literature, it has been
reported that patients with MERS generally recover
completely both clinically and radiologically [3,7].
The limitation of our study was that it was retrospective,
and the number of patients is small compared to the large
case series described previously. However, we believe these
cases will contribute to the literature in terms of reporting
infectious agents such as SARS CoV-2 and C. burnetti as
infectious etiologies of MERS.
In conclusion, MERS is an acute encephalopathy with a
good prognosis and should be considered by neurologists
in differential diagnosis due to its variable clinical
presentation and specific MRI findings.
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